A Phase 3 Study of Solosec® for the Treatment of Trichomoniasis

Clinical trial NCT03935217 · COMPLETED

Trial details

NCT number: NCT03935217
Sponsor: Lupin Research Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Trichomonas Infection

Start date: 2019-04-23
Primary completion: 2020-03-02
Enrollment: 147

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.